I got you with the first sentence and agree. The remainder of your point got a bit cloudy. But, the last sentence..."products don't just sell themselves", while somewhat pedestrian, captures my point. Global commercialization is not within Elite's grasp. A big pharma firm has the existing value chain capabilities and adding Elite's products to it offers scale without cost. Win-MF-Win!
News 
Market Data 
Discover 
